About the problem
In almost 70% of countries, there is not enough blood. It happens because of a lack of logistics and (bez also) infrastructure deficiencies. These need to buy blood from one other. As a result, a lot of blood components can be wasted during the transportation process.
Another important problem is a crisis coming into Asia. Because of the demographic situation, we observe that fewer and fewer people can donate blood. In 2030 we will observe that China will not have enough blood to make treatments and operations.
So, as you can observe the problem is huge. We need to find a solution to stop wasting blood. We need a tool that optimizes the logistics in managing blood.
The real question is: What we can do or improve to use blood more effectively and stop wasting it?
Start-up came with the idea
AIDA Diagnostics is a startup in the med-tech market founded in 2019 by Michał Janiszewski and Mateusz Pawełczuk. They revolutionized the blood market by combining AI and blood management. Their main goal is to reduce wasting blood by applying clinical decision support systems. It is simple assistance for doctors and regional blood banks. It decides if and how much blood transfusion is required. Even though previously few people tried to apply similar systems of blood management, AIDA’s was first using AI.
The three main goals of AIDA are to: reduce blood wasting, improve blood management and apply clinical decision support systems.
The E-Documentation for blood storage management is a tool that allows us to do several things. The first one is running the electronic registry of blood components going in and out of the blood bank. Also, it is generating all the reports and documentation necessary to be compliant with the regulation issued by the Minister of Health of Poland.
The CDSS system is designed to provide information about the validity of transfusions. It is based on the expertise included in the guidelines for the treatment with blood and its components issued by the Polish Ministry of Health. The system suggestions are based directly on the guidelines. Moreover, it can provide intel on the strength of scientific evidence supporting its recommendations. One of the similar solutions abroad reduces the number of unnecessary transfusions by up to 60%! Furthermore, they benefit patients while reducing the cost of blood therapy.
The third of AIDA products is AIDA Blood. It’s a tool that provides quick and user-friendly access to all the data needed to manage blood inventory. Also, it allows its users to analyze the potential results of their decisions thanks to AI and Data Science-based algorithms. It helps with the assessment of the risk of facing a shortage of blood components for the following days.
The future of AIDA
AIDA is a system created basically on Excel. Data that enter the data (regarding the number of used blood units and those that are in stock). Then, based on new and archival data, the system informs how many doses will be needed in four ahead. The target plan is to integrate AIDA with hospital systems. This innovative system aims to create an ecosystem that will be able to ensure an abundance of blood in hospitals. As a result, much less blood will be wasted.
For example, one of the hospitals in Poland used AIDA. It turns out that they menage to reduce out-of-date blood from 8.4% to only 2.5%.